0001493152-23-009212.txt : 20230328 0001493152-23-009212.hdr.sgml : 20230328 20230328091015 ACCESSION NUMBER: 0001493152-23-009212 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230327 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morris Jeffrey Allen CENTRAL INDEX KEY: 0001959175 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36457 FILM NUMBER: 23766396 MAIL ADDRESS: STREET 1: 1729 TRIANGLE PARK DR. CITY: MARYVILLE STATE: TN ZIP: 37801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROVECTUS BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000315545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900031917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10025 INVESTMENT DRIVE STREET 2: SUITE 250 CITY: KNOXVILLE STATE: TN ZIP: 37932 BUSINESS PHONE: 865-769-4011 MAIL ADDRESS: STREET 1: 10025 INVESTMENT DRIVE STREET 2: SUITE 250 CITY: KNOXVILLE STATE: TN ZIP: 37932 FORMER COMPANY: FORMER CONFORMED NAME: PROVECTUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020417 FORMER COMPANY: FORMER CONFORMED NAME: ZAMAGE DIGITAL IMAGING INC DATE OF NAME CHANGE: 20011126 FORMER COMPANY: FORMER CONFORMED NAME: SPM GROUP INC DATE OF NAME CHANGE: 19920703 3 1 ownership.xml X0206 3 2023-03-27 0 0000315545 PROVECTUS BIOPHARMACEUTICALS, INC. PVCT 0001959175 Morris Jeffrey Allen 1729 TRIANGLE PARK DRIVE MARYVILLE TN 37801 0 0 1 0 Common Stock 18500000 D Series D-1 Convertible Preferred Stock 3806990 D 8% Secured Convertible Promissory Note 2.862 2023-05-05 2023-05-05 Series D-1 Convertible Preferred Stock 500000 D The reporting person has sole voting and dispositve power over 12,000,000 shares of Common Stock, plus 6,500,000 shares of Common Stock owned through a retirement plan. The reporting person has sole voting and dispositve power over 3,806,990 shares of Series D-1 Convertible Preferred Stock, convertible into 38,069,900 shares of Common Stock. The outstanding principal and interest of the Note will automatically convert into shares of Series D-1 Convertible Preferred Stock at a price of $2.862 per share on 05/05/2023. /s/ Jeffrey Allen Morris 2023-03-27